10x Genomics Opens Well Above IPO Price

10x Genomics TXG made its public debut Thursday morning, opening at $54 after being priced at $39 per share.

The firm plans to trade on the Nasdaq under ticker symbol "TXG.”

See Aslo: 10X Genomics IPO: What You Need To Know

10x Genomics markets the Chromium single-cell analysis system and assay kits, announced its plans for an IPO last month. Initially, its filing said it was looking to raise up to $100 million.

JPMorgan, Goldman Sachs and Bank of America Merrill Lynch are acting as lead joint book-running managers for the offering. Cowen is acting as lead manager for the offering.

Posted In: NewsIPOs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...